Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women

American Journal of Public Health

Volumn 94, Issue 7, 2004, Pages 1133-1140

  Cook, Judith A ^a   Grey, Dennis ^a   Burke, Jane ^a   Cohen, Mardge H ^b   Gurtman, Alejandra C ^c   Richardson, Jean L ^d   Wilson, Tracey E ^e   Young, Mary A ^f   Hessol, Nancy A ^g  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Jr Hospital of Cook County   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DEATH; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MENTAL HEALTH; MENTAL HEALTH SERVICE; MORTALITY; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; SUBSTANCE ABUSE;

EID: 3042737078     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.7.1133     Document Type: Article

References (27)

1. Reichlin S. Mechanisms of disease: neuroendocrine-immune interactions. N Engl J Med. 1993;329: 1246-1253.
2. Herbert TB, Cohen S. Depression and immunity: a meta-analytical review. Psychol Bull. 1993;113: 472-486.
3. Rovner BW, German PS, Brant LJ, Clark R, Burton L, Folstein MF. Depression and mortality in nursing homes. JAMA 1991;265:993-996.
4. Sambamoorthi U, Walkup J, Olfson M, Crystal S. Antidepressant treatment and health services utilization among HIV-infected Medicaid patients diagnosed with depression. J Gen Intern Med. 2000;15:311-320.
5. Lyketsos CG, Hoover DR, Guccione M, et al. Depressive symptoms as predictors of medical outcomes in HIV infection. JAMA. 1993;270:2563-2567.
6. Vedhara K, Giovanni S, McDermott M. Disease progression in HIV-positive women with moderate to severe immunosuppression: the role of depression. Behav Med. 1999;25:43-47.
7. Low-Beer S, Chan K, Yip B, et al. Depressive symptoms decline among persons on HIV protease inhibitors. J Acquir Immune Defic Syndr. 2000;23: 295-301.
8. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the National Comorbidity Survey: 1. Lifetime prevalence, chronicity and recurrence. J Affective Disord. 1993;29:85-96.
9. Cook JA, Cohen MH, Burke J, et al. Effects of depressive symptoms and mental health quality of life on use of highly active antiretroviral therapy among HIV-seropositive women. J Acquir Immune Defic Syndr. 2002;30:401-409.
10. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999; 13:1763-1769.
11. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogenous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2001;26:82-92.
12. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [published erratum appears in Ann Intern Med. 2002;136:253]. Ann Intern Med. 2000;133:21-30.
13. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection [published erratum appears in Ann Intern Med. 2002;136:253]. Ann Intern Med. 2000;133:21-30.
14. Cohen MH, French AL, Benning L, et al. Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy. Am J Med. 2002;113:91-98.
15. Ickovics JR, Hamburger ME, Vlahov D, et al. Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV epidemiology research study. JAMA. 2001;285:1466-1474.
16. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
17. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
18. Breslau N. Depressive symptoms, major depression, and generalized anxiety: a comparison of self-reports on CES-D and results from diagnostic interviews. Psychiatry Res. 1985;15:219-229.
19. Zimmerman M, Coryell W. Screening for major depressive disorder in the community: a comparison of measures. Psychol Asses. 1994;6:71-74.
20. Ickovics JR, Thayaparan B, Ethier K. Women and AIDS: a contextual analysis. In: Baum A, Revenson T, Singer J, eds. Handbook of Health Psychology. Hillsdale, NJ: Erlbaum; 2000:821-839.
21. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA. 2000;283(3):381-390.
22. US Dept of Health and Human Services/Henry J. Kaiser Family Foundation. Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents [monograph online] 2002 Feb. Available at: http://hivatis.org. Accessed March 6, 2002.
23. Wilson, TE, Barron Y, Cohen M, et al. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis. 2002;34: 529-534.
24. Barkan SE, Melnick SL, Preston-Martin S, et al. The Women's Interagency HIV Study. Epidemiology. 1998;9(2):117-125.
25. Judd FK, Cockram AM, Komiti A, Mijch AM, Hoy J, Bell R. Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study. Aust N Z J Psychiatry. 2000;34:1015-1021.
26. Cook JA, Cohen MH, Grey DD, et al. Use of highly active antiretroviral therapy in a cohort of HIV-seropositive women. Am J Public Health. 2002;92: 82-87.
27. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.